Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menopausal depression: hormone therapy versus sertraline
ACTRN12624000475549Phase 3Recruiting
- Sponsor
- Monash University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of estradiol, progesterone and sertraline in major depressive disorder (MDD) and menopause (2 arms), sponsored by Monash University. Primary endpoints: Menopausal depression and Quality of life. Started Jun 2025; status: recruiting.
02
Drugs
estradiolprogesteronesertraline
03
Conditions
major depressive disorder (MDD)menopause
Beyond the preview
Go deeper on ACTRN12624000475549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000475549.